Company Algeta ASA Xetra
Equities
GJ9
NO0010239437
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
2014 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
2014 | Actavis : M&A frenzy in healthcare sector | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,924,985 | 793,344 ( 1.806 %) | 0 | 1.806 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ALGETA Stock
- GJ9 Stock
- Company Algeta ASA